CY-09

Manufacturer	MedChem Express
Category	Inhibitors
Type	Inhibitors
Specific against	other
Amount	25mg
Item no.	HY-103666-25mg
CASRN	1073612-91-5
Available
Product Description	CY-09 is a selective and direct NLRP3 inhibitor. CY-09 directly binds to the ATP-binding motif of NLRP3 NACHT domain and inhibits NLRP3 ATPase activity, resulting in the suppression of NLRP3 inflammasome assembly and activation.
StorageTemperature	Powder -20°C 3 years, 4°C 2 years; In solvent -80°C 6 months, -20°C 1 month
Applications	COVID-19-immunoregulation
Formula	C19H12F3NO3S2
References	[1].Jiang H, et al. Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders. J Exp Med. 2017 Nov 6; 214(11):3219-3238.
MolecularWeight	423.43
Research Area	Inflammation/Immunology
Solubility	DMSO : ≥ 150 mg/mL (354.25 mM) \| H2O : < 0.1 mg/mL (insoluble)
Target	NOD-like Receptor (NLR)
Pathway	Immunology/Inflammation

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 25mg

available

Delivery expected until 4/20/2023

Compare

Add to wishlist

Recommend by mail

Request delivery time

Ask a technical question